Roy Golan

Roy Golan is a registered CPA and experienced financial advisor, investor, and board member. Currently, they serve as the Chief Financial Officer at LiveKidney and are a board member of My Size, Inc. and NeuroSense Therapeutics. Golan has held key roles in various organizations, including Executive Vice President and CFO at BioSight Ltd., and played a pivotal role in several IPOs and mergers, including the successful acquisition of NeuroDerm by Mitsubishi Tanabe. Golan holds a B.A. in Business and Accounting from The College of Management Academic Studies and a Legislate Law Master (LL.M.) degree from Bar-Ilan University.